4.5 Article Proceedings Paper

Brief intervention for hazardous and harmful drinkers in the emergency department

Journal

ANNALS OF EMERGENCY MEDICINE
Volume 51, Issue 6, Pages 742-750

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.annemergmed.2007.11.028

Keywords

-

Funding

  1. NIAAA NIH HHS [R01 AA12417-01A1, R01 AA012417-01A1, R01 AA012417] Funding Source: Medline
  2. NIDA NIH HHS [K23 DA015144, K23 DA15144] Funding Source: Medline

Ask authors/readers for more resources

Study objective: To determine the efficacy of emergency practitioner-performed brief intervention for hazardous/harmful drinkers in reducing alcohol consumption and negative consequences in an emergency department (ED) setting. Methods: A randomized clinical trial (Project ED Health) was conducted in an urban ED from May 2002 to November 2003 for hazardous/harmful drinkers. Patients 18 years or older who screened above National Institute for Alcohol Abuse and Alcoholism guidelines for low-risk drinking or presented with an injury in the setting of alcohol ingestion were eligible. The mean number of drinks per week and binge-drinking episodes during the past 30 days were collected at 6 and 12 months; negative consequences and use of treatment services, at 12 months. A Brief Negotiation Interview performed by emergency practitioners was compared to scripted Discharge Instructions. Results: A total of 494 hazardous/harmful drinkers were studied. The 2 groups were similar with respect to baseline characteristics. In the Brief Negotiation Interview group, the mean number of drinks per week at 12 months was 3.8 less than the 13.6 reported at baseline. The Discharge Instructions group decreased 2.6 from 12.4 at baseline. Likewise, binge-drinking episodes per month decreased by 2.0 from a baseline of 6.0 in the Brief Negotiation Interview group and 1.5 from 5.4 in the Discharge Instructions group. For each outcome, the time effect was significant and the treatment effect was not. Conclusion: Among ED patients with hazardous/harmful drinking, we did not detect a difference in efficacy between emergency practitioner-performed Brief Negotiation Interview and Discharge Instructions. Further studies to test the efficacy of brief intervention in the ED are needed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Health Care Sciences & Services

Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH)

Gail D'Onofrio, E. Jennifer Edelman, Kathryn F. Hawk, Michael V. Pantalon, Marek C. Chawarski, Patricia H. Owens, Shara H. Martel, Paul VanVeldhuisen, Neal Oden, Sean M. Murphy, Kristen Huntley, Patrick G. O'Connor, David A. Fiellin

IMPLEMENTATION SCIENCE (2019)

Article Integrative & Complementary Medicine

Improved sexual functioning of long-term daily users of Mitragyna speciosa (Korth.)

Darshan Singh, Oliver Grundmann, Vikneswaran Murugaiyah, Azlan Bin Muhammad Rahim, Marek Chawarski, Vicknasingam Balasingam

JOURNAL OF HERBAL MEDICINE (2020)

Article Substance Abuse

Safety of Gabapentin Prescribed for Any Indication in a Large Clinical Cohort of 571,718 US Veterans with and without Alcohol Use Disorder

Christopher T. Rentsch, Kenneth L. Morford, David A. Fiellin, Kendall J. Bryant, Amy C. Justice, Janet P. Tate

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2020)

Article Medicine, General & Internal

Barriers and Facilitators to Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine

Kathryn F. Hawk, Gail D'Onofrio, Marek C. Chawarski, Patrick G. O'Connor, Ethan Cowan, Michael S. Lyons, Lynne Richardson, Richard E. Rothman, Lauren K. Whiteside, Patricia H. Owens, Shara H. Martel, Edouard Coupet, Michael Pantalon, Leslie Curry, David A. Fiellin, E. Jennifer Edelman

JAMA NETWORK OPEN (2020)

Article Emergency Medicine

A qualitative study of emergency department patients who survived an opioid overdose: Perspectives on treatment and unmet needs

Kathryn Hawk, Lauretta E. Grau, David A. Fiellin, Marek Chawarski, Patrick G. O'Connor, Nikolas Cirillo, Chris Breen, Gail D'Onofrio

Summary: Emergency medicine clinicians have the unique position to provide interventions to enhance linkage to evidence-based treatment for opioid use disorder in the acute overdose period. Little is known about patient perspectives to effectively engage patients immediately following opioid overdose. This study explored patients' perspectives on substance use treatment, perceived needs, and contextual factors influencing their engagement with treatment and other patient support services in the acute post-opioid overdose period.

ACADEMIC EMERGENCY MEDICINE (2021)

Article Substance Abuse

Psychiatric comorbidity and order of condition onset among patients seeking treatment for chronic pain and opioid use disorder

Declan T. Barry, Mark Beitel, Christopher J. Cutter, David A. Fiellin, Lynn M. Madden, Nathan Lipkind, Pooja Bollampally, Christopher Liong, Richard S. Schottenfeld

Summary: The study compared psychiatric comorbidity among patients seeking treatment for chronic pain and opioid use disorder (OUD) based on the order of condition onset, revealing differences in psychiatric comorbidity associated with the onset of conditions, indicating potential different pathways for the emergence of chronic pain and OUD.

DRUG AND ALCOHOL DEPENDENCE (2021)

Article Psychiatry

COVID-19 Impact on Healthcare and Supportive Services for People Who Use Drugs (PWUDs) in Malaysia

Balasingam Vicknasingam, Nur Afiqah Mohd Salleh, Weng-Tink Chooi, Darshan Singh, Norzarina Mohd Zaharim, Adeeba Kamarulzaman, Marek C. Chawarski

Summary: A qualitative study conducted in Malaysia during the initial stages of the COVID-19 response found significant changes in healthcare and support services, but relatively low rates of COVID-19 infections among people who use drugs.

FRONTIERS IN PSYCHIATRY (2021)

Editorial Material Substance Abuse

Low- and very low-dose buprenorphine induction: new(ish) uses for an old(ish) medication?

Melissa B. Weimer, David A. Fiellin

ADDICTION (2022)

Article Substance Abuse

The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus study

Niranjan S. Karnik, John Marsden, Connor McCluskey, Randy A. Boley, Katharine A. Bradley, Cynthia Campbell, Megan E. Curtis, David Fiellin, Udi Ghitza, Kathryn Hefner, Yih-Ing Hser, R. Kathryn McHugh, Sterling M. McPherson, Larissa J. Mooney, Landhing M. Moran, Sean M. Murphy, Robert P. Schwartz, Dikla Shmueli-Blumberg, Matisyahu Shulman, Kari A. Stephens, Katherine E. Watkins, Roger D. Weiss, Li-Tzy Wu

Summary: The aim of this study was to develop a core outcomes set for evaluating treatments for opioid use disorder. After an expert consensus study and discussion, five core outcomes were determined. This helps improve consistency and comparability in research.

ADDICTION (2022)

Article Substance Abuse

Association of topiramate prescribed for any indication with reduced alcohol consumption in electronic health record data

Henry R. Kranzler, Shirley H. Leong, Michelle Naps, Emily E. Hartwell, David A. Fiellin, Christopher T. Rentsch

Summary: The study suggests that topiramate may be associated with reduced drinking in individuals without a history of alcohol use disorder, especially among those with higher baseline drinking levels and higher average daily dosage of the medication.

ADDICTION (2022)

Article Emergency Medicine

Early emergency department experience with 7-day extended-release injectable buprenorphine for opioid use disorder

Gail D'Onofrio, Jeanmarie F. Perrone, Kathryn Hawk, Ethan Cowan, Ryan McCormack, Edouard H. Coupet Jr, Patricia H. Owens, Shara Martel, Kristen L. Huntley, Sharon R. Walsh, Michelle Lofwall, Andrew Herring, ED INNOVATION Investigators

Summary: With the opioid overdose epidemic escalating, there is an urgent need for treatment innovations, such as the use of extended-release buprenorphine (XR-BUP), to address barriers faced by both patients and clinicians in the emergency department (ED). This article provides information on the pharmacokinetics of a new 7-day XR-BUP formulation and reports on the feasibility of its use in the ED setting based on early experiences from a clinical trial. The medication has been approved for the treatment of moderate to severe opioid use disorder (OUD) in adults and our report includes data on approximately 800 ED patients who received the XR-BUP preparation between June 2020 and July 2023.

ACADEMIC EMERGENCY MEDICINE (2023)

Article Psychology, Clinical

Perspectives on and experiences of emergency department-initiated buprenorphine among clinical pharmacists: A multi-site qualitative study

Marissa Justen, E. Jennifer Edelman, Marek Chawarski, Edouard Coupet Jr, Ethan Cowan, Michael Lyons, Patricia Owens, Shara Martel, Lynne Richardson, Richard Rothman, Lauren Whiteside, Patrick G. O'Connor, Evan Zahn, Gail D'Onofrio, David A. Fiellin, Kathryn F. Hawk

Summary: Clinical pharmacists play a crucial role in promoting ED-initiated buprenorphine for opioid use disorder. The study identified six themes, including varying levels of pharmacist comfort and experience with ED-initiated buprenorphine, unique challenges for patients with OUD, and the critical role of pharmacists in successful program implementation and quality improvement. Training and leveraging existing pharmacy resources were identified as facilitation needs to support practice change.

JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT (2023)

Article Biology

Kratom and Pain Tolerance: A Randomized Placebo-Controlled, Double-Blind Study

Balasingam Vicknasingam, Weng Tink Chooi, Azlan Abdul Rahim, Dinesh Ramachandram, Darshan Singh, Surash Ramanathan, Nur Sabrina Mohd Yusof, Hadzliana Zainal, Vikneswaran Murugaiyah, Ralitza Gueorguieva, Sharif Mahsufi Mansor, Marek C. Chawarski

YALE JOURNAL OF BIOLOGY AND MEDICINE (2020)

Article Medicine, Research & Experimental

The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for Three Parallel Multi-Site Stepped Care Effectiveness Studies for Unhealthy Alcohol Use in HIV-Positive Patients

E. Jennifer Edelman, Stephen A. Maisto, Nathan B. Hansen, Christopher J. Cutter, James Dziura, Lynn E. Fiellin, Patrick G. O'Connor, Roger Bedimo, Cynthia Gibert, Vincent C. Marconi, David Rimland, Maria C. Rodriguez-Barradas, Michael S. Simberkoff, Amy C. Justice, Kendall J. Bryant, David A. Fiellin

CONTEMPORARY CLINICAL TRIALS (2017)

No Data Available